4.4 Article

At least it won't hurt: the personal risks of antibiotic exposure

Journal

CURRENT OPINION IN PHARMACOLOGY
Volume 11, Issue 5, Pages 446-452

Publisher

ELSEVIER SCI LTD
DOI: 10.1016/j.coph.2011.06.011

Keywords

-

Funding

  1. Pfizer
  2. European Commission [241796, LSHP-CT-2007-037941]
  3. Swiss National Science Foundation [3200B0-122324/1]
  4. University of Geneva Hospitals, Geneva, Switzerland

Ask authors/readers for more resources

This review presents recent evidence regarding the adverse effects of antibiotic therapy mediated by collateral damage to commensal flora. Two major drivers have characterized recent research in this field: new perspectives into human microbiota afforded by next-generation DNA sequencing techniques and ongoing attention to antimicrobial resistance. New molecular techniques have illustrated that antibiotic therapy can disturb human microbiota, and that these changes are associated with infection. Concurrently, epidemiologic studies using patient-level data offer new insights into the role of antibiotics in the emergence, selection and spread of antimicrobial resistance, and Clostridium difficile infection (CDI).

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available